Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Cash-to-Debt : 0.24 (As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is Gulf Pharmaceutical Industries PSC Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Gulf Pharmaceutical Industries PSC's cash to debt ratio for the quarter that ended in Dec. 2023 was 0.24.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Gulf Pharmaceutical Industries PSC couldn't pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Gulf Pharmaceutical Industries PSC's Cash-to-Debt or its related term are showing as below:

ADX:JULPHAR' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.09 Med: 0.2 Max: 0.24
Current: 0.24

During the past 13 years, Gulf Pharmaceutical Industries PSC's highest Cash to Debt Ratio was 0.24. The lowest was 0.09. And the median was 0.20.

ADX:JULPHAR's Cash-to-Debt is ranked worse than
73.21% of 1049 companies
in the Drug Manufacturers industry
Industry Median: 0.95 vs ADX:JULPHAR: 0.24

Gulf Pharmaceutical Industries PSC Cash-to-Debt Historical Data

The historical data trend for Gulf Pharmaceutical Industries PSC's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Gulf Pharmaceutical Industries PSC Cash-to-Debt Chart

Gulf Pharmaceutical Industries PSC Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

0.09

0.15

0.22

0.13

0.24

Gulf Pharmaceutical Industries PSC Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial															0.13	0.14	0.18	0.19	0.24

Competitive Comparison of Gulf Pharmaceutical Industries PSC's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Gulf Pharmaceutical Industries PSC's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gulf Pharmaceutical Industries PSC's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gulf Pharmaceutical Industries PSC's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Gulf Pharmaceutical Industries PSC's Cash-to-Debt falls into.

Gulf Pharmaceutical Industries PSC Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Gulf Pharmaceutical Industries PSC's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	261.3	/	(254	+	856.6)
	=	0.24

Gulf Pharmaceutical Industries PSC's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	261.3	/	(254	+	856.6)
	=	0.24

Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Gulf Pharmaceutical Industries PSC Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Gulf Pharmaceutical Industries PSC's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Airport Road, P.O. Box 997, Digdaga, Ras Al Khaimah, ARE

Website

https://www.julphar.net

Gulf Pharmaceutical Industries PSC is a generic pharmaceutical manufacturer in the Middle East and North Africa. The company manufactures and sells pharmaceuticals and medical compounds, including cosmetics compounds, and drugs. It operates in four segments: Manufacturing, Planet, Investments, and others. It maintains a diverse product portfolio that targets various therapeutic segments including Gastrointestinal Tract (GIT), Respiratory, Pain Management, Wounds & Scars, Anti-infectives, Anemia, Gynecology, Dermatology, Erectile Dysfunction, and Cardiology. The geographical segments are UAE, Other GCC countries, and Other countries.

Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Headlines

No Headlines